{"transactions":[{"id":1883122,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":113267,"kind":"person","name":"Palantoni Frank","position":1,"cik":"0001307963","reported_name":"Palantoni Frank","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-05-22T20:06:07.000Z","date":"2023-05-21","kind":"exercise","planned":false,"acquired":false,"shares":9302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":9302},"source":{"system":"sec-edgar","filing":"0001127602-23-016435","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223016435/form4.xml","form_type":"4"}},{"id":1883121,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":113267,"kind":"person","name":"Palantoni Frank","position":1,"cik":"0001307963","reported_name":"Palantoni Frank","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-22T20:06:07.000Z","date":"2023-05-21","kind":"exercise","planned":false,"acquired":true,"shares":9302,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":40332,"source":{"system":"sec-edgar","filing":"0001127602-23-016435","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223016435/form4.xml","form_type":"4"}},{"id":1911581,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":113267,"kind":"person","name":"Palantoni Frank","position":1,"cik":"0001307963","reported_name":"Palantoni Frank","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-28T20:26:54.000Z","date":"2023-04-28","kind":"grant","planned":false,"acquired":true,"shares":12658,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":12658,"derivative":{"exercise_price":2.36,"expiration_date":"2033-04-28","underlying":"Common Stock","underlying_shares":12658},"source":{"system":"sec-edgar","filing":"0001127602-23-013786","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223013786/form4.xml","form_type":"4"}},{"id":1911580,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":113267,"kind":"person","name":"Palantoni Frank","position":1,"cik":"0001307963","reported_name":"Palantoni Frank","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-04-28T20:26:54.000Z","date":"2023-04-28","kind":"grant","planned":false,"acquired":true,"shares":8032,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":8032,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":8032},"source":{"system":"sec-edgar","filing":"0001127602-23-013786","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223013786/form4.xml","form_type":"4"}},{"id":2260530,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":113267,"kind":"person","name":"Palantoni Frank","position":1,"cik":"0001307963","reported_name":"Palantoni Frank","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2022-05-23T20:15:47.000Z","date":"2022-05-21","kind":"grant","acquired":true,"shares":9302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":9302,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":9302},"source":{"system":"sec-edgar","filing":"0001127602-22-015372","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760222015372/form4.xml","form_type":"4"}},{"id":2260529,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":113267,"kind":"person","name":"Palantoni Frank","position":1,"cik":"0001307963","reported_name":"Palantoni Frank","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-23T20:15:47.000Z","date":"2022-05-21","kind":"grant","acquired":true,"shares":14402,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":14402,"derivative":{"exercise_price":1.77,"expiration_date":"2032-05-21","underlying":"Common Stock","underlying_shares":14402},"source":{"system":"sec-edgar","filing":"0001127602-22-015372","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760222015372/form4.xml","form_type":"4"}},{"id":2286822,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":113267,"kind":"person","name":"Palantoni Frank","position":1,"cik":"0001307963","reported_name":"Palantoni Frank","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2022-05-02T20:17:13.000Z","date":"2022-04-30","kind":"exercise","acquired":false,"shares":4024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4024},"source":{"system":"sec-edgar","filing":"0001127602-22-012832","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760222012832/form4.xml","form_type":"4"}},{"id":2286821,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":113267,"kind":"person","name":"Palantoni Frank","position":1,"cik":"0001307963","reported_name":"Palantoni Frank","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-02T20:17:13.000Z","date":"2022-04-30","kind":"exercise","acquired":true,"shares":4024,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":31030,"source":{"system":"sec-edgar","filing":"0001127602-22-012832","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760222012832/form4.xml","form_type":"4"}},{"id":2733365,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":113267,"kind":"person","name":"Palantoni Frank","position":1,"cik":"0001307963","reported_name":"Palantoni Frank","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-03T21:06:15.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":6475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":6475,"derivative":{"exercise_price":5.04,"expiration_date":"2031-04-30","underlying":"Common Stock","underlying_shares":6475},"source":{"system":"sec-edgar","filing":"0001127602-21-014968","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760221014968/form4.xml","form_type":"4"}},{"id":2733364,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":113267,"kind":"person","name":"Palantoni Frank","position":1,"cik":"0001307963","reported_name":"Palantoni Frank","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2021-05-03T21:06:15.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":4024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":4024,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4024},"source":{"system":"sec-edgar","filing":"0001127602-21-014968","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760221014968/form4.xml","form_type":"4"}},{"id":2738794,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":113267,"kind":"person","name":"Palantoni Frank","position":1,"cik":"0001307963","reported_name":"Palantoni Frank","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2021-04-27T20:49:50.000Z","date":"2021-04-24","kind":"exercise","acquired":false,"shares":10638,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10638},"source":{"system":"sec-edgar","filing":"0001127602-21-014522","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760221014522/form4.xml","form_type":"4"}},{"id":2738793,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":113267,"kind":"person","name":"Palantoni Frank","position":1,"cik":"0001307963","reported_name":"Palantoni Frank","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-04-27T20:49:50.000Z","date":"2021-04-24","kind":"exercise","acquired":true,"shares":10638,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":27006,"source":{"system":"sec-edgar","filing":"0001127602-21-014522","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760221014522/form4.xml","form_type":"4"}},{"id":3169362,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":113267,"kind":"person","name":"Palantoni Frank","position":1,"cik":"0001307963","reported_name":"Palantoni Frank","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2020-04-27T20:48:08.000Z","date":"2020-04-26","kind":"exercise","acquired":false,"shares":3466,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3466},"source":{"system":"sec-edgar","filing":"0001127602-20-014568","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220014568/form4.xml","form_type":"4"}},{"id":3169361,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":113267,"kind":"person","name":"Palantoni Frank","position":1,"cik":"0001307963","reported_name":"Palantoni Frank","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2020-04-27T20:48:08.000Z","date":"2020-04-24","kind":"grant","acquired":true,"shares":10638,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":10638,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10638},"source":{"system":"sec-edgar","filing":"0001127602-20-014568","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220014568/form4.xml","form_type":"4"}},{"id":3169360,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":113267,"kind":"person","name":"Palantoni Frank","position":1,"cik":"0001307963","reported_name":"Palantoni Frank","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-27T20:48:08.000Z","date":"2020-04-24","kind":"grant","acquired":true,"shares":18115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":18115,"derivative":{"exercise_price":1.86,"expiration_date":"2030-04-24","underlying":"Common Stock","underlying_shares":18115},"source":{"system":"sec-edgar","filing":"0001127602-20-014568","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220014568/form4.xml","form_type":"4"}},{"id":3169359,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":113267,"kind":"person","name":"Palantoni Frank","position":1,"cik":"0001307963","reported_name":"Palantoni Frank","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-04-27T20:48:08.000Z","date":"2020-04-26","kind":"exercise","acquired":true,"shares":3466,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16368,"source":{"system":"sec-edgar","filing":"0001127602-20-014568","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220014568/form4.xml","form_type":"4"}},{"id":3546823,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":113267,"kind":"person","name":"Palantoni Frank","position":1,"cik":"0001307963","reported_name":"Palantoni Frank","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2019-04-29T21:08:37.000Z","date":"2019-04-26","kind":"grant","acquired":true,"shares":3466,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":3466,"derivative":{"underlying":"Common Stock","underlying_shares":3466},"source":{"system":"sec-edgar","filing":"0001127602-19-016497","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219016497/form4.xml","form_type":"4"}},{"id":3546822,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":113267,"kind":"person","name":"Palantoni Frank","position":1,"cik":"0001307963","reported_name":"Palantoni Frank","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-29T21:08:37.000Z","date":"2019-04-26","kind":"grant","acquired":true,"shares":6519,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":6519,"derivative":{"exercise_price":5.67,"expiration_date":"2029-04-26","underlying":"Common Stock","underlying_shares":6519},"source":{"system":"sec-edgar","filing":"0001127602-19-016497","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219016497/form4.xml","form_type":"4"}},{"id":3955205,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":113267,"kind":"person","name":"Palantoni Frank","position":1,"cik":"0001307963","reported_name":"Palantoni Frank","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-27T21:40:18.000Z","date":"2018-04-27","kind":"grant","acquired":true,"shares":2857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to 1/12th of the shares subject to the option for each month of service following the date of grant."}],"balance_after":2857,"derivative":{"exercise_price":7.8,"expiration_date":"2028-04-27","underlying":"Common Stock","underlying_shares":2857},"source":{"system":"sec-edgar","filing":"0001127602-18-015451","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760218015451/form4.xml","form_type":"4"}},{"id":3955204,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":113267,"kind":"person","name":"Palantoni Frank","position":1,"cik":"0001307963","reported_name":"Palantoni Frank","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-04-27T21:40:18.000Z","date":"2018-04-27","kind":"grant","acquired":true,"shares":2564,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12902,"source":{"system":"sec-edgar","filing":"0001127602-18-015451","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760218015451/form4.xml","form_type":"4"}},{"id":4340659,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":113267,"kind":"person","name":"Palantoni Frank","position":1,"cik":"0001307963","reported_name":"Palantoni Frank","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-01T20:52:51.000Z","date":"2017-04-28","kind":"grant","acquired":true,"shares":2857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to 1/12th of the shares subject to the option for each month of service following the date of grant."}],"balance_after":2857,"derivative":{"exercise_price":15.61,"expiration_date":"2027-04-28","underlying":"Common Stock","underlying_shares":2857},"source":{"system":"sec-edgar","filing":"0001127602-17-016068","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760217016068/form4.xml","form_type":"4"}},{"id":4340658,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":113267,"kind":"person","name":"Palantoni Frank","position":1,"cik":"0001307963","reported_name":"Palantoni Frank","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-05-01T20:52:51.000Z","date":"2017-04-28","kind":"grant","acquired":true,"shares":1281,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10338,"source":{"system":"sec-edgar","filing":"0001127602-17-016068","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760217016068/form4.xml","form_type":"4"}}]}